FindTrial
Sign In

Side effects of drugs used in ICU

"Pattern of adverse drug reaction in Covid-19 patients admitted in medical intensive care unit of a Covid-19 hospital"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/028800
Enrollment
100
Registered
2020-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: J100- Influenza due to other identifiedinfluenza virus with pneumonia

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Government Institute of Medical Science
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Patients diagnosed with COVID 19 disease admitted in the COVID ICU will be included in the study.

Exclusion criteria

Exclusion criteria: NIL

Design outcomes

Primary

MeasureTime frame
Adverse Drug reactionTimepoint: baseline, day 1, 2 , 3, 4, 5, 6, 7,8, 9, 10, 11,12, 13, 14,—

Secondary

MeasureTime frame
1. Demographic parameters (age and gender). 2. Number of medications. 3. Associated co-morbid conditions. 4. Length of ICU stay. Timepoint: at admission and discharge—

Countries

India

Contacts

Public ContactDr Nazia Nazir

Government Institute of Medical Science

nazunazir@gmail.com9560102957

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026